Close Menu

NEW YORK (GenomeWeb) – Bruker reported after the close of the market Monday that its fourth quarter revenues were up 4 percent year over year.

For the three months ended Dec. 31, the company reported revenues of $553.6 million, up from $530.5 million in Q4 2017, and beating the average analyst estimate of $544.6 million.

Organic revenue growth during the quarter was 4 percent, with acquisitions contributing 3 percent and foreign currency translation lowering revenues 2 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.